The high-grade B-cell lymphomas: double hit and more
Edited by Associate Editor Michael Hallek and Podcast Editor Laurie H. Sehn, this Review Series highlights the biologic features of, clinical phenotype of,
Related Articles
Clive Peedell (@drpeedell.bsky.social)
Consultant Clinical Oncologist NHS advocate and campaigner Politically centre left Wealth inequality creates health inequality
Biomarker-Guided Treatment Approaches Transform Lung and GI Cancer Management
Experts across the fields of lung and GI cancer share key information and insights from 2 recent OncLive biomarker consortiums.
Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis
Key Points. Air pollution exposure is common, and may increase risk of developing blood clots.Greater long-term exposure to air pollution (i.e., PM2.5, NOx
Ponsegromab for the Treatment of Cancer Cachexia | NEJM
Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a…
#ASH24: Treatments for R/R AML, maintenance strategies, and mutation- and MRD-informed decisions
Catch up with our live social media coverage of treatments for R/R AML, maintenance therapy, and mutation- and MRD-informed decisions from the 66th ASH Annual…
Non-T-depleted haploidentical transplantation in patients with secondary AML
Arnon Nagler, MD, Chaim Sheba Medical Center, Tel-Aviv, Israel, comments on the value of non-T-depleted haploidentical transplantation in patients with secondary acute myeloid leukemia (AML)…
FAST-Forward: safety of ultra-hypofractionated radiotherapy on cardiac health
Icro Meattini, MD, University of Florence, Florence, Italy, comments on the results of the FAST-Forward trial (ISRCTN19906132), stating that ultra-hypofractionated radiotherapy, as per the trial,…
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma
Multiple myeloma (MM) is a dreadful disease, marked by the uncontrolled proliferation of clonal plasma cells (PCs) within the bone marrow (BM). MM is characterized…
IO-202 Plus Azacitidine Elicits Responses in HMA-Naive Chronic Myelomonocytic Leukemia
IO-202 plus azacitidine elicited an ORR of 66.7% in patients with HMA-naive chronic myelomonocytic leukemia.